CCRN Valuation

Cross Country Healthcare Inc

Add to Watchlist

Advanced Chart

13.590

-0.16(-1.164%)1D

Overview
Forecast
Valuation
Earnings

CCRN Relative Valuation

CCRN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CCRN is overvalued; if below, it's undervalued.

Historical Valuation

Cross Country Healthcare Inc (CCRN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.41 is considered Fairly compared with the five-year average of 21.27. The fair price of Cross Country Healthcare Inc (CCRN) is between 11.13 to 16.37 according to relative valuation methord.

Relative Value

Fair Zone

11.13-16.37

Current Price：13.59

Fair

75.51

Trailing

Forward

11.54

EV/EBITDA

Cross Country Healthcare Inc. (CCRN) has a current EV/EBITDA of 11.54. The 5-year average EV/EBITDA is 7.72. The thresholds are as follows: Strongly Undervalued below 1.46, Undervalued between 1.46 and 4.59, Fairly Valued between 10.85 and 4.59, Overvalued between 10.85 and 13.98, and Strongly Overvalued above 13.98. The current Forward EV/EBITDA of 11.54 falls within the Overvalued range.

50.16

EV/EBIT

Cross Country Healthcare Inc. (CCRN) has a current EV/EBIT of 50.16. The 5-year average EV/EBIT is 21.00. The thresholds are as follows: Strongly Undervalued below -38.91, Undervalued between -38.91 and -8.96, Fairly Valued between 50.96 and -8.96, Overvalued between 50.96 and 80.92, and Strongly Overvalued above 80.92. The current Forward EV/EBIT of 50.16 falls within the Historic Trend Line -Fairly Valued range.

0.41

Cross Country Healthcare Inc. (CCRN) has a current PS of 0.41. The 5-year average PS is 0.41. The thresholds are as follows: Strongly Undervalued below 0.22, Undervalued between 0.22 and 0.32, Fairly Valued between 0.51 and 0.32, Overvalued between 0.51 and 0.61, and Strongly Overvalued above 0.61. The current Forward PS of 0.41 falls within the Historic Trend Line -Fairly Valued range.

9.47

P/OCF

Cross Country Healthcare Inc. (CCRN) has a current P/OCF of 9.47. The 5-year average P/OCF is 6.17. The thresholds are as follows: Strongly Undervalued below 1.76, Undervalued between 1.76 and 3.97, Fairly Valued between 8.37 and 3.97, Overvalued between 8.37 and 10.58, and Strongly Overvalued above 10.58. The current Forward P/OCF of 9.47 falls within the Overvalued range.

11.33

P/FCF

Cross Country Healthcare Inc. (CCRN) has a current P/FCF of 11.33. The 5-year average P/FCF is 6.93. The thresholds are as follows: Strongly Undervalued below 1.34, Undervalued between 1.34 and 4.13, Fairly Valued between 9.73 and 4.13, Overvalued between 9.73 and 12.52, and Strongly Overvalued above 12.52. The current Forward P/FCF of 11.33 falls within the Overvalued range.

Cross Country Healthcare Inc (CCRN) has a current Price-to-Book (P/B) ratio of 1.08. Compared to its 3-year average P/B ratio of 1.60 , the current P/B ratio is approximately -32.22% higher. Relative to its 5-year average P/B ratio of 2.07, the current P/B ratio is about -47.47% higher. Cross Country Healthcare Inc (CCRN) has a Forward Free Cash Flow (FCF) yield of approximately 7.58%. Compared to its 3-year average FCF yield of 23.09%, the current FCF yield is approximately -67.18% lower. Relative to its 5-year average FCF yield of 12.48% , the current FCF yield is about -39.26% lower.

1.08

P/B

Median3y

1.60

Median5y

2.07

7.58

FCF Yield

Median3y

23.09

Median5y

12.48

Competitors Valuation Multiple

The average P/S ratio for CCRN's competitors is 0.36, providing a benchmark for relative valuation. Cross Country Healthcare Inc Corp (CCRN) exhibits a P/S ratio of 0.41, which is 12.99% above the industry average. Given its robust revenue growth of -19.34%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CCRN.O

Cross Country Healthcare Inc

R C M Technologies Inc

AMN Healthcare Services Inc

0.31

-11.14%

753.07M

Performance Decomposition

Market capitalization of CCRN decreased by 8.91% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -33.04 to -52.51.

The secondary factor is the Revenue Growth, contributed -19.34%to the performance.

Overall, the performance of CCRN in the past 1 year is driven by P/E Change. Which is more unsustainable.

-19.34%

339.77M → 274.07M

Revenue Growth

-48.52%

-4.72 → -2.43

Margin Expansion

58.95%

-33.04 → -52.51

P/E Change

-8.91%